From Ozempic to Mounjaro

Disclaimer: Please ensure you chat with your care provider before making any changes. They are going to support you to do it as safely as possible.  

With Ozempic in high demand and little to none to go around, and Mounjaro entering the market here in Canada, some or many of you may be considering switching from one to the other. 

Ozempic and Mounjaro are the main drugs on the market for both diabetes and obesity management. But is their dosing the same? Can you just switch without considering anything at all? (Hint: don’t do that.)

Let’s get into it. 

Related weight loss medication videos: 

▪️ Mounjaro is coming to Canada: https://youtu.be/pvIZK7pu27Q 

▪️ Ozempic Alternatives: https://youtu.be/8zsjXu8kLs4 

▪️ Muscle Loss with Ozempic, Wegovy & Mounjaro: https://youtu.be/lnEH-v64aG0 

– 

Live in Alberta? Come see me at my Pharmacist-led Obesity Clinic at Apothecare Pharmacy – http://apothecarerx.ca 

Products to support your weight loss journey: 

USA: https://amzn.to/3RC7MSd

Canada: https://amzn.to/45gq4vg

– 

Sign up for my newsletter: http://eepurl.com/gdB2qn 

– 

Have questions or need support on your weight-loss journey? Book a consultation with me: https://calendly.com/drdanconsult/he

Dr. Dan

Follow me on social media for regular updates – @TheOfficialDrDan

Subscribe to my newsletter for a heads-up on all new content.

Sharing is caring! Here’s the social, email, and even text link – https://healthevolved.co/ozempic-to-mounjaro

If you need some coaching support on your weight management journey, you can book a consultation with me to see if you’d be a good fit for our program. 

Questions or comments? Please send them my way on our Contact Us page!

Share:

More Posts

Orforglipron: A Diabetes Game Changer Hidden in Plain Sight

Orforglipron is a once-daily oral GLP-1 medication showing powerful results for people with type 2 diabetes. It lowers A1C and supports significant weight loss—all without injections, food restrictions, or lifestyle coaching. Based on the ACHIEVE-1 trial, this treatment could change how early type 2 diabetes is managed.

Peripheral Artery Disease (PAD) & Semglutide

If walking causes burning or cramping in your legs, it could be more than just aging or being out of shape—it might be Peripheral Artery Disease (PAD). Learn how semaglutide, commonly known for weight loss and diabetes, is now showing promise in improving mobility and reducing leg pain by improving blood flow.

CagriSema vs Tirzepatide

CagriSema and Tirzepatide are two of the most talked-about names in obesity treatment—now see how they compare. Explore the latest clinical results, real-world impacts, and what sets each medication apart when it comes to weight loss and metabolic health.

Mazdutide: China’s GLP-1 Gamechanger

Mazdutide is a new GLP-1/glucagon receptor agonist from China, showing promising weight loss results in recent trials. With up to 14% reduction in a lower-BMI population, it raises key questions about how it compares to Wegovy, Zepbound, and the future of obesity treatment.

Send Us A Message

Try My New Calorie Calculator!

Calculate your daily calorie and protein targets to help you achieve your weight goals.

Try My New Calorie Calculator!

Calculate your daily calorie and protein targets to help you achieve your weight goals.